Cannabis in Switzerland – a Global Overview
- Average Rating:
- 0
- Categories:
- Administrative Law | Business | International Law | Webinar with CLE credit
- Faculty:
- Kai-Friedrich Niermann | Daniel Haymann, MBA | Peter Steger
- Duration:
- 1 Hour 04 Minutes
- Format:
- Audio and Video
- SKU:
- INCBA05262021OD
- License:
- Access for 6 month(s) after purchase.
Description
Located in the center of Europe and without being a member of the European Union, Switzerland is home to Europe’s most progressive cannabis laws. Cannabis with a THC content below 1 pct is not considered a narcotic drug, which led to the development of one of the most active and mature CBD markets in the world. Most recently, Switzerland passed regulations which allow for the initiation of pilot schemes wherein adult-use cannabis can be legally produced and distributed to registered users, which will make Switzerland, next to the Netherlands, the first region in Europe to allow for a fully legalized adult-use cannabis supply chain. The Swiss Parliament further adopted a proposed amendment to the Narcotics Act which shall facilitate patient’s access to medicinal cannabis, and provide a framework for exports. This one hour session will touch on the legal framework of recreational and medicinal cannabis in Switzerland and provide a high-level overview of the newest developments, the challenges, as well as the opportunities in Switzerland’s dynamic cannabis market.
Credits
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are generally eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
The on-demand version of this webinar is eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees.
(Default credit disclaimer updated 02.08.2024)
For current accreditation status, please select your jurisdiction below.
Handouts
| Swissmedic CBD implementation guide (265.6 KB) | Available after Purchase | ||
| Cannabis in Switzerland (6.9 KB) | Available after Purchase | ||
Faculty
Kai-Friedrich Niermann Related Seminars and Products
Lawyer
KFN+
Kai is characterized by his outstanding expertise and diverse practice in the cannabis industry. With a broad range of expertise in cannabis and business law, he provides comprehensive legal support to companies and individuals.
From contract drafting and company formation to day-to-day legal support, he assists cannabis companies with customized solutions in all legal matters, including white collar criminal law where necessary.
Kai is also the author of the blog canna-biz.legal, where he positions himself as an expert in the thriving cannabis business. Canna-biz.legal not only provides insights into the legal status of cannabis in Germany and Europe today, but also current developments and offers resources for businesses and interested parties.
His work spans all aspects of the cannabis industry, from advising companies on cultivation licenses and production regulations to assisting with regulatory issues in product development. His deep understanding of the complex legal framework in this sector makes him a sought-after contact.
Kai and his law firm KFN+ advise large CBD and medical cannabis companies, as well as companies and associations interested in the emerging recreational cannabis market. He is also advisor to the European Industrial Hemp Association (EIHA), which has submitted a joint application to the EU Commission for authorization as a novel food for various CBD products.
With an international perspective, Kai operates not only nationally, but also across borders. His network in the industry enables him to support companies in their global activities and adapt to the challenges of an ever-changing legal landscape.
Kai regularly speaks at international cannabis conferences on topics related to the German and European legal framework for cannabis, and publishes articles at Krautinvest, BusinessCann and in law journals.
Born in Löhne/Westf. in 1972, studied law at the Universities of Marburg, Adelaide (Australia), Cologne, legal assistant at the press center of the German Bundestag (2000-2002), worked for the Berlin District Court, for the Director of Public Prosecution in Berlin, for the Berlin Office for the Protection of the Constitution and the Hong Kong Consulate General.
Areas of Law:
- Legal Cannabis Consulting
- Regulatory approvals for medical cannabis and CBD
- Business law (company, commercial and contract law)
- Law of torts
- Criminal business law
Daniel Haymann, MBA Related Seminars and Products
Legal Counsel
MME Legal | Tax | Compliance
Daniel Haymann specializes in corporate and commercial law. Based on his extensive business experience, he has a good feel for new markets and understands the requirements of go-to-market and scale-up strategies. As an interdisciplinary and hands-on advisor, his focus is on investments, venture capital and financing transactions as well as regulatory issues in the healthcare and consumer goods sectors.
He advises investors, start-ups and vertically integrated companies along the value chain, including on regulatory issues relating to THC, CBD and other cannabinoids and psychoactive substances, GMP and GDP standards, food and cosmetics regulations and approval procedures before Swissmedic, the Swiss remedy institute.
Daniel is co-founder and co-chair of the European branch of the International Cannabis Bar Association (INCBA Europe). As a Swiss-Israeli dual citizen, he also focuses on serving clients with connections to Israel and strengthening the relevant business relationships.
Prior to his career as a lawyer, Daniel spent over 10 years in senior positions as a commodity trader for multinational corporations.
Peter Steger Related Seminars and Products
CEO and Owner | President of IG MedCann
SPAGYRIK Produktions AG/ HEIDAK AG
Peter Steger is a lawyer and entrepreneur. As managing director and co-owner, he runs a GMPcompliant pharmaceutical manufacturing company, Spagyrik Produktions AG. This company produces various herbal medicines, including cannabis medicines in the form of tinctures and oils (THC and CBDcontaining products).
Spagyrik Produktions AG has all the necessary licences in this regard. Peter Steger is also co-owner of the distribution company HEIDAK AG and the German subsidiary HEIDAK GmbH. These distribute natural medicines, care products, packaging material and other products.